Survodutide

Where Survodutide fits in incretin research

Survodutide is a dual agonist acting at the GLP-1 and glucagon receptors. Pairing those two targets is a different strategy from the GIP and GLP-1 combination seen in Tirzepatide, and that contrast is part of why the compound turns up in comparative metabolic research. It is investigational and not approved as a medicine anywhere. Supply is thinner than for the better-known incretin peptides, so fewer brands carry it and stock can come and go. The listings collected here show who currently offers Survodutide, the strength of each vial, the kit size and the resulting price per milligram. When a brand has supplied an independent HPLC or mass-spec report, it is shown on the product so you are not relying on the label alone. A listing without a report is worth weighing accordingly. Because a smaller catalogue can mean less familiar vendors, the escrow model is particularly useful here. You pay GLP1 Forum Escrow, the brand ships the order, and payment is released only after delivery. A claim opened before release keeps your money held while the problem is reviewed, and an upheld claim is refunded to your Escrow Wallet.

Frequently asked questions

Why are there fewer Survodutide listings than Tirzepatide?

Survodutide is newer to the research market and fewer manufacturers produce it, so the number of brands and the stock on hand can change. The listings shown reflect what vetted brands currently offer. Comparing price per milligram and lab coverage is still worthwhile, even with a shorter list.

How is Survodutide different from other incretin research peptides?

It targets two receptors, GLP-1 and glucagon, rather than the GIP and GLP-1 pairing of Tirzepatide or the three-receptor profile of Retatrutide. That makes it a useful comparator in metabolic research designs. It is investigational, not approved as a medicine, and is listed for laboratory study only.

Am I protected if a Survodutide parcel is lost in transit?

Yes, provided you have not released payment. Open a claim from your order page; orders still in transit after a set number of days are also flagged for review. Your funds remain in escrow during the review, and an upheld claim is refunded to your Escrow Wallet.